US Pharma MarketingThe post Abbott’s dual ablation catheter lands FDA approval appeared first on Medical Device Network.
Abbott’s dual ablation catheter lands FDA approval
FDA clearance for Abbott’s TactiFlex Duo follows the dual ablation catheter’s receipt of a European CE mark in January 2026. FDA clearance for Abbott’s TactiFlex Duo follows the dual ablation catheter’s receipt of a European CE mark in January 2026. The FDA’s clearance of Abbott’s TactiFlex Duo was based on data from the company’s FlexPulse IDE study. Credit: Michael Vi/Shutterstock.com The US Food and Drug Administration (FDA) has approved Abbott’s TactiFlex Duo, a dual ablation catheter indicated for the treatment of atrial fibrillation (AFib). TactiFlex Duo provides both radiofrequency (RF) ablation and pulsed-field ablation (PFA), providing clinicians with greater optionality…
FDA clearance for Abbott’s TactiFlex Duo follows the dual ablation catheter’s receipt of a European CE mark in January 2026.
Source: Medical Device Network